EMA Panel Recommends Midostaurin for AML
Following FDA approval, a European Medicines Agency panel recommended
midostaurin for acute myeloid leukemia and systemic mastocytosis.
U.S. News & World Report Delays Hospital Rankings Over Data Errors
The agency is postponing the release of its annual hospital rankings
after finding errors in the data used to compile the report.
FDA Commissioner Will Set Stricter Prescriber Education Standards for Opioid Manufacturers
The U.S. Food and Drug Administration Commissioner will require
manufacturers to provide extended training for opioid prescribers,
including education about alternative pain management methods.
This is (supposed to be) a reflective diary by a (not very) anonymous biomedical scientist who works somewhere in the south of England. One day this diary may well be submitted to the Health and Care Professions Council as evidence of ongoing continual professional development....
No comments:
Post a Comment